APA (7th ed.) Citation

Schulman, G., & Ritz, E. (2017). Risk factors for progression of chronic kidney disease in the EPPIC trials and the effect of AST-120. Clinical and experimental nephrology, 22(2), . https://doi.org/10.1007/s10157-017-1447-0

Chicago Style (17th ed.) Citation

Schulman, Gerald, and Eberhard Ritz. "Risk Factors for Progression of Chronic Kidney Disease in the EPPIC Trials and the Effect of AST-120." Clinical and Experimental Nephrology 22, no. 2 (2017). https://doi.org/10.1007/s10157-017-1447-0.

MLA (9th ed.) Citation

Schulman, Gerald, and Eberhard Ritz. "Risk Factors for Progression of Chronic Kidney Disease in the EPPIC Trials and the Effect of AST-120." Clinical and Experimental Nephrology, vol. 22, no. 2, 2017, https://doi.org/10.1007/s10157-017-1447-0.